drugset / Trial / NCT04438174
Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds
RandomizedParallel-groupSingle-blindTreatment
Summary
A prospective randomized controlled study to determine the safety and feasibility of using processed amniotic fluid (pAF) to expedite healing in chronic wounds.
Timeline
- Start
- 2022-08
- Primary completion
- 2023-03
- Completion
- 2023-03
Outcome
Outcome not reported
Stopped (Enrollment): “Enrollment was halted prematurely after enrolling one participant due to difficulty finding eligible participants.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Processed Amniotic Fluid | Unknown | 1 ml | Other |
Indications
No indication recorded.